APA

Nadali G., Tavecchia L., Zanolin E., Bonfante V., Viviani S., Camerini E., Musto P., Di Renzo N., Carotenuto M., Chilosi M., Krampera M. & Pizzolo G. (19980512). Serum level of the soluble form of the CD30 molecule identifies patients with Hodgkin's disease at high risk of unfavorable outcome. : Blood.

Chicago

Nadali G, Tavecchia L, Zanolin E, Bonfante V, Viviani S, Camerini E, Musto P, Di Renzo N, Carotenuto M, Chilosi M, Krampera M and Pizzolo G. 19980512. Serum level of the soluble form of the CD30 molecule identifies patients with Hodgkin's disease at high risk of unfavorable outcome. : Blood.

Harvard

Nadali G., Tavecchia L., Zanolin E., Bonfante V., Viviani S., Camerini E., Musto P., Di Renzo N., Carotenuto M., Chilosi M., Krampera M. and Pizzolo G. (19980512). Serum level of the soluble form of the CD30 molecule identifies patients with Hodgkin's disease at high risk of unfavorable outcome. : Blood.

MLA

Nadali G, Tavecchia L, Zanolin E, Bonfante V, Viviani S, Camerini E, Musto P, Di Renzo N, Carotenuto M, Chilosi M, Krampera M and Pizzolo G. Serum level of the soluble form of the CD30 molecule identifies patients with Hodgkin's disease at high risk of unfavorable outcome. : Blood. 19980512.